[go: up one dir, main page]

HK1133192A1 - Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic - Google Patents

Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic Download PDF

Info

Publication number
HK1133192A1
HK1133192A1 HK09111397.7A HK09111397A HK1133192A1 HK 1133192 A1 HK1133192 A1 HK 1133192A1 HK 09111397 A HK09111397 A HK 09111397A HK 1133192 A1 HK1133192 A1 HK 1133192A1
Authority
HK
Hong Kong
Prior art keywords
tablet
extended release
dosage form
curing
tablets
Prior art date
Application number
HK09111397.7A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1133192B (en
Inventor
William Henry Mckenna
Richard Owen Mannion
Edward Patrick O’Donnell
Haiyong Hugh Huang
Original Assignee
Purdue Pharma Lp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38754532&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1133192(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Purdue Pharma Lp filed Critical Purdue Pharma Lp
Priority claimed from HK08109790.5A external-priority patent/HK1118225B/en
Publication of HK1133192A1 publication Critical patent/HK1133192A1/en
Publication of HK1133192B publication Critical patent/HK1133192B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/005—Coating of tablets or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/06—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of pills, lozenges or dragees
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29B—PREPARATION OR PRETREATMENT OF THE MATERIAL TO BE SHAPED; MAKING GRANULES OR PREFORMS; RECOVERY OF PLASTICS OR OTHER CONSTITUENTS OF WASTE MATERIAL CONTAINING PLASTICS
    • B29B7/00—Mixing; Kneading
    • B29B7/02—Mixing; Kneading non-continuous, with mechanical mixing or kneading devices, i.e. batch type
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29B—PREPARATION OR PRETREATMENT OF THE MATERIAL TO BE SHAPED; MAKING GRANULES OR PREFORMS; RECOVERY OF PLASTICS OR OTHER CONSTITUENTS OF WASTE MATERIAL CONTAINING PLASTICS
    • B29B7/00—Mixing; Kneading
    • B29B7/80—Component parts, details or accessories; Auxiliary operations
    • B29B7/88—Adding charges, i.e. additives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C35/00—Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
    • B29C35/02—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould
    • B29C35/04—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould using liquids, gas or steam
    • B29C35/045—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould using liquids, gas or steam using gas or flames
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C35/00—Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
    • B29C35/16—Cooling
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C37/00—Component parts, details, accessories or auxiliary operations, not covered by group B29C33/00 or B29C35/00
    • B29C37/0025—Applying surface layers, e.g. coatings, decorative layers, printed layers, to articles during shaping, e.g. in-mould printing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C43/00—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
    • B29C43/003—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor characterised by the choice of material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C43/00—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
    • B29C43/02—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor of articles of definite length, i.e. discrete articles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C43/00—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
    • B29C43/32—Component parts, details or accessories; Auxiliary operations
    • B29C43/52—Heating or cooling
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C71/00—After-treatment of articles without altering their shape; Apparatus therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C71/00—After-treatment of articles without altering their shape; Apparatus therefor
    • B29C71/009—After-treatment of articles without altering their shape; Apparatus therefor using gases without chemical reaction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C35/00—Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
    • B29C35/02—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould
    • B29C35/04—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould using liquids, gas or steam
    • B29C35/045—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould using liquids, gas or steam using gas or flames
    • B29C2035/046—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould using liquids, gas or steam using gas or flames dried air
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C35/00—Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
    • B29C35/16—Cooling
    • B29C2035/1658—Cooling using gas
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2071/00—Use of polyethers, e.g. PEEK, i.e. polyether-etherketone or PEK, i.e. polyetherketone or derivatives thereof, as moulding material
    • B29K2071/02—Polyalkylene oxides, e.g. PEO, i.e. polyethylene oxide, or derivatives thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/0005—Condition, form or state of moulded material or of the material to be shaped containing compounding ingredients
    • B29K2105/0035—Medical or pharmaceutical agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/25—Solid
    • B29K2105/251—Particles, powder or granules
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2995/00—Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
    • B29K2995/0037—Other properties
    • B29K2995/0088—Molecular weight
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/753—Medical equipment; Accessories therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mechanical Engineering (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Thermal Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Plasma & Fusion (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK09111397.7A 2006-08-25 2008-09-03 Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic HK1133192B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84024406P 2006-08-25 2006-08-25
US840244P 2006-08-25
HK08109790.5A HK1118225B (en) 2006-08-25 2008-09-03 Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
HK08109790.5A Addition HK1118225B (en) 2006-08-25 2008-09-03 Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic

Related Child Applications (1)

Application Number Title Priority Date Filing Date
HK08109790.5A Division HK1118225B (en) 2006-08-25 2008-09-03 Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic

Publications (2)

Publication Number Publication Date
HK1133192A1 true HK1133192A1 (en) 2010-03-19
HK1133192B HK1133192B (en) 2011-08-19

Family

ID=

Also Published As

Publication number Publication date
ES2411696T3 (es) 2013-07-08
EP2399579B9 (en) 2013-07-24
HK1165317A1 (en) 2012-10-05
EP2292230B1 (en) 2012-05-23
KR20120105566A (ko) 2012-09-25
JP5642736B2 (ja) 2014-12-17
ES2357376T3 (es) 2011-04-25
IL217790A0 (en) 2012-03-29
US20130260015A1 (en) 2013-10-03
US9486413B2 (en) 2016-11-08
CY1111896T1 (el) 2015-11-04
PT2399579E (pt) 2013-06-24
CL2007002485A1 (es) 2008-01-25
PE20150340A1 (es) 2015-02-28
AP2009004770A0 (en) 2009-02-28
BR122016004010B8 (pt) 2021-05-25
SI2292229T1 (en) 2012-09-28
US20170128369A1 (en) 2017-05-11
IL241122B (en) 2019-05-30
HK1165316A1 (en) 2012-10-05
SA07280459B1 (ar) 2011-07-20
US20250235407A1 (en) 2025-07-24
RS51591B (en) 2011-08-31
JP2016222698A (ja) 2016-12-28
US10076499B2 (en) 2018-09-18
DE602007012747D1 (de) 2011-04-07
CR10691A (es) 2009-06-05
US20150265600A1 (en) 2015-09-24
PL2080514T3 (pl) 2011-09-30
PL2399580T3 (pl) 2013-12-31
US20170348240A1 (en) 2017-12-07
IL217794A (en) 2015-09-24
US20150265599A1 (en) 2015-09-24
CA2707204C (en) 2015-06-23
EP2399580A1 (en) 2011-12-28
US20240408024A1 (en) 2024-12-12
US9770417B2 (en) 2017-09-26
DK2399579T3 (da) 2013-06-17
EA201300465A1 (ru) 2013-08-30
PT2384754E (pt) 2013-05-24
US9763886B2 (en) 2017-09-19
US9775810B2 (en) 2017-10-03
JP2010501543A (ja) 2010-01-21
CN103861111B (zh) 2017-04-12
EP2082742B1 (en) 2010-12-01
ES2388591T3 (es) 2012-10-16
PL2292230T3 (pl) 2012-10-31
US20210000747A1 (en) 2021-01-07
HK1156845A1 (en) 2012-06-22
US9095615B2 (en) 2015-08-04
PL2384754T3 (pl) 2013-12-31
US11298322B2 (en) 2022-04-12
US20170128372A1 (en) 2017-05-11
US9492391B2 (en) 2016-11-15
MY146650A (en) 2012-09-14
US20130251802A1 (en) 2013-09-26
US20170319488A1 (en) 2017-11-09
EP2311459A1 (en) 2011-04-20
CN102657630A (zh) 2012-09-12
IL241121A0 (en) 2015-11-30
CN102688241A (zh) 2012-09-26
ATE489953T1 (de) 2010-12-15
GT200900023BA (es) 2018-09-28
US20170319495A1 (en) 2017-11-09
IL217792A0 (en) 2012-03-29
AR103463A2 (es) 2017-05-10
CN107412179B (zh) 2020-09-04
PL1897545T3 (pl) 2010-02-26
US20170319491A1 (en) 2017-11-09
US20170128373A1 (en) 2017-05-11
US20130251799A1 (en) 2013-09-26
US9492390B2 (en) 2016-11-15
PT2343071E (pt) 2013-05-29
US20150037413A1 (en) 2015-02-05
US9492393B2 (en) 2016-11-15
CN107412179A (zh) 2017-12-01
DK2082742T3 (da) 2011-03-21
AU2007287341A1 (en) 2008-02-28
IL197214A0 (en) 2009-12-24
US20230270684A1 (en) 2023-08-31
IL217794A0 (en) 2012-03-29
ATE444070T1 (de) 2009-10-15
PE20191048A1 (es) 2019-08-06
US9486412B2 (en) 2016-11-08
US8815289B2 (en) 2014-08-26
US8808741B2 (en) 2014-08-19
SI1897545T1 (sl) 2010-01-29
JO2858B1 (en) 2015-03-15
CL2017000669A1 (es) 2017-11-10
IL197214A (en) 2015-09-24
IL217789A0 (en) 2012-03-29
PT1897545E (pt) 2009-12-16
SI2311459T1 (sl) 2012-10-30
SI2292230T1 (sl) 2012-09-28
KR101568100B1 (ko) 2015-11-12
KR20120105565A (ko) 2012-09-25
ME01187B (me) 2011-10-31
US9492392B2 (en) 2016-11-15
DE202007011825U1 (de) 2008-04-30
US20130259940A1 (en) 2013-10-03
ME01339B (me) 2013-12-20
KR101496510B1 (ko) 2015-03-03
KR101205579B1 (ko) 2012-11-28
DOP2011000255A (es) 2011-10-15
US12246094B2 (en) 2025-03-11
US20090081290A1 (en) 2009-03-26
CA2661573A1 (en) 2008-02-28
EP2399579A1 (en) 2011-12-28
US20170319493A1 (en) 2017-11-09
US20190000767A1 (en) 2019-01-03
DK2399580T3 (da) 2013-06-24
EA023807B1 (ru) 2016-07-29
EA200900343A1 (ru) 2009-08-28
RS52401B (en) 2013-02-28
US20130259939A1 (en) 2013-10-03
HRP20130539T1 (en) 2013-07-31
CY1111897T1 (el) 2015-11-04
ES2411695T3 (es) 2013-07-08
RS52402B (en) 2013-02-28
HRP20120670T1 (hr) 2012-09-30
MX360849B (es) 2018-11-20
US20130251797A1 (en) 2013-09-26
DE602007010963D1 (de) 2011-01-13
KR20110119847A (ko) 2011-11-02
ES2390419T3 (es) 2012-11-12
US9545380B2 (en) 2017-01-17
CN103861111A (zh) 2014-06-18
CN105213345A (zh) 2016-01-06
CY1111887T1 (el) 2015-11-04
HK1154788A1 (en) 2012-05-04
US12280152B2 (en) 2025-04-22
US20240115507A1 (en) 2024-04-11
US20150037411A1 (en) 2015-02-05
HK1246175A1 (zh) 2018-09-07
EP2070538A1 (en) 2009-06-17
WO2008023261A1 (en) 2008-02-28
EP2343071B1 (en) 2013-03-20
ES2361721T3 (es) 2011-06-21
US20250073173A1 (en) 2025-03-06
US9775808B2 (en) 2017-10-03
US20180153815A1 (en) 2018-06-07
ES2334466T3 (es) 2010-03-10
US20170354607A1 (en) 2017-12-14
US20150335584A1 (en) 2015-11-26
HK1154491A1 (en) 2012-04-27
EA031873B1 (ru) 2019-03-29
US20170348241A1 (en) 2017-12-07
US20150335585A1 (en) 2015-11-26
RS51664B (en) 2011-10-31
US9770416B2 (en) 2017-09-26
MY161079A (en) 2017-04-14
NZ597760A (en) 2013-04-26
CY1113231T1 (el) 2016-04-13
US8911719B2 (en) 2014-12-16
AR109796A2 (es) 2019-01-23
IL217792A (en) 2015-09-24
ES2388615T3 (es) 2012-10-17
EP1897545A1 (en) 2008-03-12
EP2311459B1 (en) 2012-06-27
US11826472B2 (en) 2023-11-28
EP2292229B1 (en) 2012-05-23
KR101649838B1 (ko) 2016-08-19
EP1897545B1 (en) 2009-09-30
RS51678B (en) 2011-10-31
HRP20120641T1 (hr) 2012-08-31
SI2082742T1 (sl) 2011-03-31
ME01064B (me) 2012-10-20
US10076498B2 (en) 2018-09-18
CN101583360B (zh) 2014-02-26
US20170128440A1 (en) 2017-05-11
US11304909B2 (en) 2022-04-19
EP2082742A1 (en) 2009-07-29
US20170065527A1 (en) 2017-03-09
US20180153814A1 (en) 2018-06-07
CN105267170A (zh) 2016-01-27
US9101661B2 (en) 2015-08-11
CY1110573T1 (el) 2015-04-29
TW200824722A (en) 2008-06-16
US20170319490A1 (en) 2017-11-09
US20170246116A1 (en) 2017-08-31
US20140030327A1 (en) 2014-01-30
HRP20110130T1 (hr) 2011-03-31
KR101787605B1 (ko) 2017-10-19
EP2343071A1 (en) 2011-07-13
CL2014001029A1 (es) 2014-09-12
JP2012167102A (ja) 2012-09-06
RS52798B (en) 2013-10-31
JP2012229249A (ja) 2012-11-22
JP2012229250A (ja) 2012-11-22
JP5069300B2 (ja) 2012-11-07
IL241121A (en) 2017-09-28
JP5980881B2 (ja) 2016-08-31
TN2009000059A1 (fr) 2010-08-19
US20150335583A1 (en) 2015-11-26
US20130251801A1 (en) 2013-09-26
EP2070538B1 (en) 2010-12-01
EP2292229A1 (en) 2011-03-09
HK1165318A1 (en) 2012-10-05
PT2082742E (pt) 2011-03-02
CO6160317A2 (es) 2010-05-20
ES2417334T3 (es) 2013-08-07
US20210000748A1 (en) 2021-01-07
MY153092A (en) 2014-12-31
PL2070538T3 (pl) 2011-05-31
US20140024669A1 (en) 2014-01-23
PL2343071T3 (pl) 2013-12-31
ATE499101T1 (de) 2011-03-15
KR101455914B1 (ko) 2014-11-03
RS52779B (en) 2013-10-31
CN102743355B (zh) 2014-12-24
CN105267170B (zh) 2019-01-01
US9775811B2 (en) 2017-10-03
HRP20120613T1 (hr) 2012-08-31
US20250082581A1 (en) 2025-03-13
US8894988B2 (en) 2014-11-25
DK2080514T3 (da) 2011-05-16
US20170319498A1 (en) 2017-11-09
DK2292229T3 (da) 2012-08-13
US9492389B2 (en) 2016-11-15
RS52813B (en) 2013-10-31
US20170128375A1 (en) 2017-05-11
UA104745C2 (ru) 2014-03-11
HRP20130433T1 (en) 2013-06-30
PT2070538E (pt) 2011-03-02
ME01255B (me) 2013-06-20
DK2070538T3 (da) 2011-03-21
JP2012236835A (ja) 2012-12-06
BRPI0714539B8 (pt) 2021-05-25
HK1118225A1 (en) 2009-02-06
CN102688241B (zh) 2017-04-12
US20140031381A1 (en) 2014-01-30
JP2012136543A (ja) 2012-07-19
PE20080765A1 (es) 2008-06-13
US20150335582A1 (en) 2015-11-26
US9775812B2 (en) 2017-10-03
DK2343071T3 (da) 2013-05-13
SI2343071T1 (sl) 2013-07-31
CR20140340A (es) 2014-10-16
EP2384754B1 (en) 2013-03-20
IL241122A0 (en) 2015-11-30
RS52463B (en) 2013-02-28
US20170128370A1 (en) 2017-05-11
MX2009002023A (es) 2009-03-05
PT2080514E (pt) 2011-05-24
US20180369150A1 (en) 2018-12-27
US8894987B2 (en) 2014-11-25
US20150335580A1 (en) 2015-11-26
ES2358066T3 (es) 2011-05-05
HK1154789A1 (en) 2012-05-04
CN102657630B (zh) 2014-10-01
KR20090045381A (ko) 2009-05-07
ME01550B (me) 2014-04-20
CN102743355A (zh) 2012-10-24
GT200900023A (es) 2010-11-05
BRPI0714539A2 (pt) 2014-02-25
US8846086B2 (en) 2014-09-30
SI2399579T1 (sl) 2013-07-31
US20130259938A1 (en) 2013-10-03
EP2080514A1 (en) 2009-07-22
HRP20090688T1 (hr) 2010-02-28
KR20170118249A (ko) 2017-10-24
IL217787A0 (en) 2012-03-29
US9775809B2 (en) 2017-10-03
DE602007002596D1 (de) 2009-11-12
DE602007010974D1 (de) 2011-01-13
CY1113141T1 (el) 2016-04-13
DOP2009000026A (es) 2009-07-15
AU2007287341B2 (en) 2011-08-25
US20230134700A1 (en) 2023-05-04
SI2399580T1 (sl) 2013-07-31
JP5373133B2 (ja) 2013-12-18
CY1113220T1 (el) 2016-04-13
JP6286491B2 (ja) 2018-02-28
PL2082742T3 (pl) 2011-05-31
ATE489954T1 (de) 2010-12-15
CN102688213A (zh) 2012-09-26
DK2292230T3 (da) 2012-08-20
HK1138498A1 (en) 2010-08-27
ZA200900755B (en) 2009-12-30
US9763933B2 (en) 2017-09-19
AR062511A1 (es) 2008-11-12
UA96306C2 (ru) 2011-10-25
PT2292230E (pt) 2012-08-28
DK2384754T3 (da) 2013-05-06
PL2311459T3 (pl) 2012-12-31
ES2417335T3 (es) 2013-08-07
EP2292230A1 (en) 2011-03-09
US20150265601A1 (en) 2015-09-24
JP2015044834A (ja) 2015-03-12
KR20160099738A (ko) 2016-08-22
US20130251800A1 (en) 2013-09-26
DK1897545T3 (da) 2010-02-08
CA2707204A1 (en) 2008-02-28
PT2311459E (pt) 2012-09-26
KR20140049085A (ko) 2014-04-24
US20150028512A1 (en) 2015-01-29
EP2399580B1 (en) 2013-04-03
MA30766B1 (fr) 2009-10-01
AR109797A2 (es) 2019-01-23
DK2311459T3 (da) 2012-09-10
BR122016004010B1 (pt) 2020-11-24
CA2661573C (en) 2010-10-26
KR101514388B1 (ko) 2015-04-23
EP2384754A1 (en) 2011-11-09
US20240226019A1 (en) 2024-07-11
US9095614B2 (en) 2015-08-04
US20130251798A1 (en) 2013-09-26
PE20091184A1 (es) 2009-08-03
NZ574447A (en) 2012-04-27
PT2399580E (pt) 2013-07-05
US20230310326A1 (en) 2023-10-05
CN105213345B (zh) 2019-04-19
AT11571U1 (de) 2011-01-15
SI2070538T1 (sl) 2011-03-31
US20170319497A1 (en) 2017-11-09
IL217791A (en) 2015-09-24
HRP20110147T1 (hr) 2011-04-30
EP2399579B1 (en) 2013-04-03
TWI341213B (en) 2011-05-01
SI2080514T1 (sl) 2011-05-31
US20170319496A1 (en) 2017-11-09
US20170319489A1 (en) 2017-11-09
RS52793B (en) 2013-10-31
US11304908B2 (en) 2022-04-19
US9084816B2 (en) 2015-07-21
HRP20110375T1 (hr) 2011-06-30
US20150037412A1 (en) 2015-02-05
ME01580B (me) 2014-09-20
PL2399579T3 (pl) 2013-12-31
US20170319494A1 (en) 2017-11-09
PL2292229T3 (pl) 2012-10-31
US11938225B2 (en) 2024-03-26
US8821929B2 (en) 2014-09-02
KR20150082669A (ko) 2015-07-15
PT2292229E (pt) 2012-08-28
EA201171403A1 (ru) 2012-05-30
RS51162B (sr) 2010-10-31
HRP20130444T1 (en) 2013-06-30
JO3323B1 (ar) 2019-03-13
EA018311B1 (ru) 2013-07-30
US8834925B2 (en) 2014-09-16
ME01482B (me) 2014-04-20
SI2384754T1 (sl) 2013-07-31
US20170319492A1 (en) 2017-11-09
IL217788A0 (en) 2012-03-29
IL217791A0 (en) 2012-03-29
HRP20130434T1 (en) 2013-06-30
IN2015DN01813A (el) 2015-07-10
HK1132189A1 (en) 2010-02-19
US11964056B1 (en) 2024-04-23
PE20140854A1 (es) 2014-07-19
US20130251796A1 (en) 2013-09-26
US20210169810A1 (en) 2021-06-10
US20170128371A1 (en) 2017-05-11
NZ608651A (en) 2014-07-25
US20210000749A1 (en) 2021-01-07
US11904055B2 (en) 2024-02-20
BRPI0714539B1 (pt) 2020-11-24
US20170128374A1 (en) 2017-05-11
EP2080514B1 (en) 2011-02-23
CN101583360A (zh) 2009-11-18

Similar Documents

Publication Publication Date Title
US12246094B2 (en) Tamper resistant dosage forms
HK1133192B (en) Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
HK1154789B (en) Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
HK1118225B (en) Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
HK1165317B (en) Pharmaceutical dosage forms
HK1154788B (en) Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
HK1165318B (en) Pharmaceutical dosage forms
HK1156845B (en) Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
HK1138498B (en) Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
HK1165316B (en) Pharmaceutical dosage forms
HK1154491B (en) Pharmaceutical dosage forms
HK1132189B (en) Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic